Milestone Scientific (MLSS)vsResMed Inc (RMD)
MLSS
Milestone Scientific
$0.39
0.00%
HEALTHCARE · Cap: $33.90M
RMD
ResMed Inc
$196.04
+0.89%
HEALTHCARE · Cap: $28.25B
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 62097% more annual revenue ($5.54B vs $8.90M). RMD leads profitability with a 27.4% profit margin vs -51.3%. RMD earns a higher WallStSmart Score of 73/100 (B).
MLSS
Avoid16
out of 100
Grade: F
RMD
Strong Buy73
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+72.0%
Fair Value
$0.95
Current Price
$0.39
$0.56 discount
Margin of Safety
-26.9%
Fair Value
$204.63
Current Price
$196.04
$8.59 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Strong operational efficiency at 35.3%
Safe zone — low bankruptcy risk
Every $100 of equity generates 23 in profit
Keeps 27 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Areas to Watch
Trading at 13.0x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : MLSS
MLSS has a balanced fundamental profile.
Bull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.4% and operating margin at 35.3%. Revenue growth of 10.8% demonstrates continued momentum.
Bear Case : MLSS
The primary concerns for MLSS are Price/Book, EPS Growth, Market Cap.
Bear Case : RMD
No major red flags identified for RMD, but monitor valuation.
Key Dynamics to Monitor
MLSS profiles as a turnaround stock while RMD is a mature play — different risk/reward profiles.
MLSS carries more volatility with a beta of 0.97 — expect wider price swings.
RMD is growing revenue faster at 10.8% — sustainability is the question.
RMD generates stronger free cash flow (520M), providing more financial flexibility.
Bottom Line
RMD scores higher overall (73/100 vs 16/100), backed by strong 27.4% margins and 10.8% revenue growth. MLSS offers better value entry with a 72.0% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Milestone Scientific
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company is headquartered in Livingston, New Jersey.
Visit Website →ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?